Completed PHASE3 INTERVENTIONAL NCT00110838

SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia

Study on Omega-3 Fatty Acids and Ventricular Arrhythmia, a Parallel, Placebo-Controlled, Double Blind Intervention Study

Sponsor: SEAFOODplus

Conditions Arrhythmia

Interventions Supplementation with fish oil versus placebo

Updated 6 times since 2017 Last updated: Jul 20, 2006 Started: Oct 31, 2001 Completion: Jan 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Arrhythmia and is currently completed. SEAFOODplus leads this study, which shows 6 recorded versions since 2001 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SEAFOODplus
Wageningen Centre for Food Sciences

Data source: Wageningen Centre for Food Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amsterdam, Netherlands , Bad Nauheim, Germany , Bad Oeynhausen, Germany , Berlin, Germany , Birmingham, United Kingdom , Brno, Czechia , Eindhoven, Netherlands , Gdansk, Poland , Ghent, Belgium , Jena, Germany and 15 more locations